Independent implant evidence support

Every implant claim has a paper trail.

Zero Prior helps value-analysis and clinical supply chain teams pressure-test high-cost implant claims before product decisions are documented — making evidence, conflicts, product differences, reimbursement context, and downstream value easier to see.

Download the one-page overview Explore pilot pathways →
Not sure where to start? Choose your path →
Structured review process · source-level audit trail · committee-facing output
Example decision record
Sample · committee-facing output
Pilot deliverable
Claim reviewed
"Superior long-term survivorship"
Direct system evidence
Limited
Design-lever evidence
Partial
Independence profile
Manufacturer-linked
Confidence ceiling
Low
Committee-facing caveat
The available evidence does not support the claimed level of confidence without important caveats.
The committee problem

Built for the messy middle of implant decisions.

High-cost implant decisions often arrive with vendor-submitted evidence, surgeon preference, reimbursement considerations, contract pressure, and limited committee bandwidth. Existing tools can help organize research and workflow, but teams still need a faster way to translate product claims into a decision record they can defend.

Are these product differences meaningful, supported, comparable, or exception-worthy?

Evidence file
Pre-audit context
Vendor claim
→Selected studies support adoption
Zero Prior question
→Direct device evidence or transferable design-lever evidence?
Evidence risk
→Short follow-up · surrogate endpoints · financial conflicts
Output
→Committee-facing decision record
Audit trail
Vendor claim → Evidence map → Independence screen → Decision record
What Zero Prior produces

What gets turned into a decision record

01
Claim support
Deliverable
Which vendor or program claims are supported, weakly supported, or not substantiated.
02
Evidence quality
Scoring
How much weight should each study carry, given its design, follow-up, endpoints, and execution.
03
Independence profile
COI screen
Who funded the evidence, who authored it, and where financial conflicts matter.
04
Registry signal screen
Real-world check
Do real-world signals align with the published story, or do they diverge.
Excerpt from a pilot output

What an honest evidence signal looks like

An RCT can ask the right question and still score Low if it has short follow-up, high attrition, or conflicted authorship.

Sample evidence record
RSA · Reverse shoulder arthroplasty
Study / claim context
Study
RCT · n=100
Question
135° vs 155° NSA in reverse shoulder arthroplasty
Funding
Manufacturer-funded
Author conflicts
Multiple disclosed author relationships
Follow-up
24 months · 32% lost
Endpoint type
Functional + radiographic
Zero Prior signal
Evidence quality
Low
Transferability
Partial
Independence
Limited independence
Confidence ceiling
Low
What the committee should document
This evidence may inform the design-lever discussion but should not be treated as direct system-specific proof of long-term superiority.

See full pilot scope →

Built for

Where device-level evidence becomes decision-relevant

Value-analysis & clinical supply chain
Implant standardization, premium-pricing review, vendor packet pressure-testing, exception governance — across user (VA director, category manager) and buyer (VP supply chain, executive clinical supply chain) altitudes.
Service-line leadership
VPs of orthopedics, surgical services, and other PPI-heavy lines making decisions across surgeon preference, supply chain, finance, and quality.
ASC administrators & chain leadership
Outpatient settings absorbing high-acuity ortho and spine cases under tight margins — where claim-level evidence and reimbursement context translation matters most.
COE platforms & surgical networks
Provider onboarding, pathway design, implant-category risk screening.
Employer purchasers & benefits advisors
Surgical pathway due diligence, COE selection, vendor evidence review.
GPOs & contracting teams
Category review, contract-renewal support, claim-level evidence layer beneath contract decisions.
Pilot engagement

Three suggested pilot pathways for a real decision question

Vendor Claim Audit · Clinical Comparability Review · ASC Implant Value Review

Each scoped to one bounded decision question — a new product request, a premium-pricing claim, a standardization or multisource decision, or a high-cost implant decision in an ambulatory surgery setting. Output: claim-support map · evidence directness assessment · COI / funding screen · clinical comparability · exception rationale · reimbursement / value context · committee-ready summary.

See full pilot scope →
What this is not
Not a clinical recommendation
Decisions remain with the committee, the physician, and the institution.
Not a product endorsement
The review evaluates the evidence behind product claims; it does not promote, sell, or represent any manufacturer.
Not a substitute for surgeon judgment or implementation planning
Surgeon familiarity, procedural training, and clinical experience remain important decision factors; the review helps clarify what the evidence does and does not support.
Publicly preregistered framework · External validation in progress · No manufacturer editorial control · Independence disclosure

If this belongs anywhere in your workflow, let's start small.

Five paths in: download the overview, submit a product decision question, discuss a possible pilot, send evidence or corrections, or join the early reviewer list.

Choose your starting point → Discuss a possible pilot →

Zero Prior is operated by Vetra Health Strategies LLC. Zero Prior content is not intended to be the sole or primary basis for any clinical, purchasing, procurement, regulatory, or investment decision with material consequences. Such decisions are made on the basis of independent professional judgment applied to the totality of available information; Zero Prior content is at most one input among many. Full COI & Independence Disclosure →